These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12643927)

  • 21. Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives.
    Tani K; Naganawa A; Ishida A; Sagawa K; Harada H; Ogawa M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2002 Apr; 10(4):1093-106. PubMed ID: 11836120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation of prostaglandin E receptor EP4 subtype in duodenal bicarbonate secretion in rats.
    Aoi M; Aihara E; Nakashima M; Takeuchi K
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G96-103. PubMed ID: 15194560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin (PG) FP and EP1 receptors mediate PGF2alpha and PGE2 regulation of interleukin-1beta expression in Leydig cell progenitors.
    Walch L; Clavarino E; Morris PL
    Endocrinology; 2003 Apr; 144(4):1284-91. PubMed ID: 12639911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.
    Schweda F; Klar J; Narumiya S; Nüsing RM; Kurtz A
    Am J Physiol Renal Physiol; 2004 Sep; 287(3):F427-33. PubMed ID: 15113745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E(2) inhibits IL-18-induced ICAM-1 and B7.2 expression through EP2/EP4 receptors in human peripheral blood mononuclear cells.
    Takahashi HK; Iwagaki H; Yoshino T; Mori S; Morichika T; Itoh H; Yokoyama M; Kubo S; Kondo E; Akagi T; Tanaka N; Nishibori M
    J Immunol; 2002 May; 168(9):4446-54. PubMed ID: 11970988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 8-iso-PGE2 stimulates anion efflux from airway epithelial cells via the EP4 prostanoid receptor.
    Joy AP; Cowley EA
    Am J Respir Cell Mol Biol; 2008 Feb; 38(2):143-52. PubMed ID: 17690331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
    Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
    Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.
    Li YJ; Wang XQ; Sato T; Kanaji N; Nakanishi M; Kim M; Michalski J; Nelson AJ; Sun JH; Farid M; Basma H; Patil A; Toews ML; Liu X; Rennard SI
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):99-107. PubMed ID: 20203295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
    Walch L; de Montpreville V; Brink C; Norel X
    Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2.
    Ono K; Akatsu T; Murakami T; Nishikawa M; Yamamoto M; Kugai N; Motoyoshi K; Nagata N
    J Endocrinol; 1998 Sep; 158(3):R1-5. PubMed ID: 9846175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
    Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA
    Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves.
    Kopp UC; Cicha MZ; Nakamura K; Nüsing RM; Smith LA; Hökfelt T
    Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1269-82. PubMed ID: 15292051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts.
    Gao M; Cao R; Du S; Jia X; Zheng S; Huang S; Han Q; Liu J; Zhang X; Miao Y; Kang J; Gustafsson JÅ; Guan Y
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8397-402. PubMed ID: 26100911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin E(2) protects human lung fibroblasts from cigarette smoke extract-induced apoptosis via EP(2) receptor activation.
    Sugiura H; Liu X; Togo S; Kobayashi T; Shen L; Kawasaki S; Kamio K; Wang XQ; Mao LJ; Rennard SI
    J Cell Physiol; 2007 Jan; 210(1):99-110. PubMed ID: 16998801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist.
    Nishigaki N; Negishi M; Ichikawa A
    Mol Pharmacol; 1996 Oct; 50(4):1031-7. PubMed ID: 8863851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of EP2 and EP4 receptor-selective agonists of prostaglandin E(2) in acute and chronic kidney failure.
    Vukicevic S; Simic P; Borovecki F; Grgurevic L; Rogic D; Orlic I; Grasser WA; Thompson DD; Paralkar VM
    Kidney Int; 2006 Sep; 70(6):1099-106. PubMed ID: 16871242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts.
    Inoue H; Takamori M; Shimoyama Y; Ishibashi H; Yamamoto S; Koshihara Y
    Br J Pharmacol; 2002 May; 136(2):287-95. PubMed ID: 12010778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP(4) receptor antagonist.
    Murase A; Taniguchi Y; Tonai-Kachi H; Nakao K; Takada J
    Life Sci; 2008 Jan; 82(3-4):226-32. PubMed ID: 18155068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of a highly selective EP4-receptor agonist. Part 1: 3,7-dithiaPG derivatives with high selectivity.
    Maruyama T; Asada M; Shiraishi T; Ishida A; Egashira H; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem Lett; 2001 Aug; 11(15):2029-31. PubMed ID: 11454473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EP4 receptor promotes invadopodia and invasion in human breast cancer.
    Tönisen F; Perrin L; Bayarmagnai B; van den Dries K; Cambi A; Gligorijevic B
    Eur J Cell Biol; 2017 Mar; 96(2):218-226. PubMed ID: 28094049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.